Study of Remote Nursing Support to Manage Side Effects in Women Receiving CDK Inhibitor Treatment for Breast Cancer

What this Trial Is About

This research investigates the use of a structured telenursing program for women with breast cancer receiving cyclin-dependent kinase CDK inhibitor therapy. These treatments can cause side effects that reduce treatment adherence and quality of life. The study aims to determine if scheduled remote nursing follow-ups can help detect and manage these side effects earlier to improve clinical outcomes and reduce complications such as hospital visits and treatment interruptions. Participants are randomly assigned to receive either standard nursing care or standard care plus a structured telenursing intervention. The telenursing program involves scheduled telephone or video consultations at set times during treatment cycles, where trained nurses assess symptoms, provide education, support medication adherence, and identify early signs of treatment toxicities. When significant issues arise, patients are referred promptly to physicians for further management. During the study, participants undergo regular assessments of side effects, treatment adherence, hospital visits, and quality of life using questionnaires and clinical data collected at baseline and throughout up to six months of treatment. The study measures the incidence and severity of adverse events, emergency visits, hospitalizations, and patient-reported outcomes to evaluate the effectiveness of the telenursing intervention compared to standard care.

Telenursing for the Early Detection and Management of Side Effects Associated With Cyclin-Dependent Kinase Inhibitors in Breast Cancer Patients